Correlation Between Denali Therapeutics and Homology Medicines

Can any of the company-specific risk be diversified away by investing in both Denali Therapeutics and Homology Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Denali Therapeutics and Homology Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Denali Therapeutics and Homology Medicines, you can compare the effects of market volatilities on Denali Therapeutics and Homology Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Denali Therapeutics with a short position of Homology Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Denali Therapeutics and Homology Medicines.

Diversification Opportunities for Denali Therapeutics and Homology Medicines

-0.11

Correlation Coefficient

Denali Therapeutics  Homology Medicines

Good diversification

The 3 months correlation between Denali and Homology is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Denali Therapeutics and Homology Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Homology Medicines and Denali Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Denali Therapeutics are associated (or correlated) with Homology Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Homology Medicines has no effect on the direction of Denali Therapeutics i.e., Denali Therapeutics and Homology Medicines go up and down completely randomly.

Pair Corralation between Denali Therapeutics and Homology Medicines

If you would invest  2,444  in Denali Therapeutics on August 30, 2024 and sell it today you would earn a total of  72.00  from holding Denali Therapeutics or generate 2.95% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	1.56%
Values	Daily Returns

Denali Therapeutics  vs.  Homology Medicines

Denali Therapeutics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Denali Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak essential indicators, Denali Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Homology Medicines

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Homology Medicines has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Homology Medicines is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Denali Therapeutics and Homology Medicines

The main advantage of trading using opposite Denali Therapeutics and Homology Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Denali Therapeutics position performs unexpectedly, Homology Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Homology Medicines will offset losses from the drop in Homology Medicines' long position.

The idea behind Denali Therapeutics and Homology Medicines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.